Enfortumab vedotin-pembrolizumab shows durability advantage over chemotherapy at three-year follow-up in bladder cancer trial ...

CRScube and Mednet demonstrate integration-free EHR-to-EDC tool designed to reduce manual transcription errors and streamline clinical data capture.

AI deployment in clinical studies requires validation framework and governance structure to address compliance gaps and ...

Cemiplimab maintains disease-free survival benefit in high-risk CSCC with 68% risk reduction versus placebo in extended ...

Most sites undercharge on research-paid items because no one reconciles the sponsor budget against the charge master. Here is ...

Headlands Research Portland site marks 50 years of continuous Alzheimer's trials, contributing to every FDA-approved ...

Forward Therapeutics' FT2109 advances to Phase 2 after clearing Phase 1 with once-daily oral dosing and a supportive safety ...

First-in-human trial targets the amygdala with focused ultrasound in MDD, raising hard questions about biomarker selection, ...

A pilot RCT links psilocybin's 25 mg dose to reduced egocentric bias in alcohol use disorder, exposing a blind spot in how ...

Jon Himoff, Chief Product Officer of Image Analysis Group (IAG), on why purpose-built imaging platforms outperform assembled ...

Advarra's IRB chief targets pre-review delays as the next efficiency frontier to reduce waiting time for researchers and trial participants.

Symphony RCT shows 55% closure rate in diabetic foot ulcers at 12 weeks, outperforming standard care alone with faster ...